1. Published Name of the Standard for which request is being made (if previously published)

 HL7 FHIR® Implementation Guide: Medicolegal Death Investigation (MDI), Release 1.1 - US Realm

2. Standards Material/Document

 Unballoted STU Update

3. Date of Request

4. Use Period

5. Reason for extension, timeline, and actions

6. Original Publication Date

7. End date of the current STU period

 Sep 30, 2024

8. Length of the requested extension

9. Review Process

 STU unballoted update, with comment period: 7/3/2023 - 8/4/2023

List of changes: http://build.fhir.org/ig/HL7/fhir-mdi-ig/change_log.html

10. HL7 Work Group making this request and date

 Public Health

10a. Requesting WG Date

 Oct 05, 2023

11. URL of approval minutes

 https://confluence.hl7.org/pages/viewpage.action?pageId=184925528#id-20231005PublicHealthWorkGroupCallMinutes-Discussionitems

12. HL7 Product Management Group

 FHIR Management Group

12a. Management Group Date of Approval

 Nov 01, 2023

13. URL of approval minutes

 https://confluence.hl7.org/pages/viewpage.action?pageId=200149623#id-20231101FMGAgenda/Minutes-Minutes

14. Is the artifact ready for final publication?

 Yes

15. If not ready, please describe remaining steps.

16. Tool name used to produce the machine processable artifacts in the IG

 Trifolia on FHIR

17. The name of the “IG artifact” within the context of the above mentioned tool.

MedicolegalDeathInvestigation, hl7-fhir-us-mdi

18. Balloted Name of the standard for which request is being made

19. Requested name for published standard. See Naming Examples

19a. Specification Feedback Name (For Search in Jira)

 Medicolegal Death Investigation (MDI) (FHIR) [FHIR-us-mdi]

20. If CMET, list IDs balloted

21. Project Insight Number

 1737

22. Document Realm

 US

23. Ballot cycle in which the document was successfully balloted

25. Affirmative

26. Negative

27. Abstentions

28. Not Returned

29. Total in ballot pool

30. Date on which final document/standards material was supplied to HQ

31. URL of publication material/ SVN repository

 https://github.com/HL7/fhir-mdi-ig

32. Publishing Facilitator

 Cynthia Bush, pdz1@cdc.gov

33. Special Publication Instructions

34. URL of ballot reconciliation document

35. Has the Work Group posted its consideration of all comments received in its reconciliation document on the ballot desktop?

36. Substantive Changes Since Last Ballot?

 No

37. Product Brief Reviewed By

38. Date Product Brief Reviewed

39. Has the Product Brief changed?

 No

40. Family

 FHIR

41. Section

 Implementation Guides

42. Topic

 Public Health

43. Please Describe the Topic

 Death investigation data exchange

44. Product Type

 Implementation Guide

45. Parent standard

 FHIR R4

46. Parent Standard Status

 Active

47. Update/replace standard

 Update STU 1

48. Common name/search keyword

 Medicolegal Death Investigation (MDI)

49. Description

 Standards and guidance on the use of FHIR resources for exchange of death investigation information among medical examiner/coroner case management systems, jurisdictional electronic death registration system (EDRS), toxicology and other laboratory information management systems (LIMS), and ancillary workflows whose systems have the capability of utilizing FHIR.

50. Stakeholders

 Clinical and Public Health Laboratories, Regulatory Agency, Standards Development Organizations (SDOs), Other (specify in text box below)

51. Vendors

 EHR, PHR, Lab, HIS, Other (please specify)

52. Providers

 Clinical and Public Health Laboratories Local and State Departments of Health Healthcare Institutions (hospitals, long term care, home care, mental health) Other (specify in text box below)

53. Benefits

 Exchange of death investigation data between medical examiner/coroner case management systems, jurisdictional electronic death registration system (EDRS), public health agency (PHA) vital records offices, toxicology and other laboratory information management systems (LIMS), and other agencies and organizations is vital records automation. Such automation adds efficiencies that dramatically improve the efficacy of event response, data analysis, and evidence-based measurable prevention of the causes of death.

54. Implementations/Case Studies

55. Development Background